NeuroSense Therapeutics Ltd. (NRSN)

USD 1.03

(-0.75%)

Total Debt Summary of NeuroSense Therapeutics Ltd.

  • NeuroSense Therapeutics Ltd.'s latest annual total debt in 2023 was 142 Thousand USD , down -32.7% from previous year.
  • NeuroSense Therapeutics Ltd.'s latest quarterly total debt in 2024 Q1 was 55 Thousand USD , down -61.27% from previous quarter.
  • NeuroSense Therapeutics Ltd. reported annual total debt of 211 Thousand USD in 2022, down -88.46% from previous year.
  • NeuroSense Therapeutics Ltd. reported annual total debt of 1.82 Million USD in 2021, down 0.0% from previous year.
  • NeuroSense Therapeutics Ltd. reported quarterly total debt of 55 Thousand USD for 2024 Q1, down -61.27% from previous quarter.
  • NeuroSense Therapeutics Ltd. reported quarterly total debt of 126 Thousand USD for 2023 Q1, down -40.28% from previous quarter.

Annual Total Debt Chart of NeuroSense Therapeutics Ltd. (2023 - 2019)

Historical Annual Total Debt of NeuroSense Therapeutics Ltd. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 142 Thousand USD -32.7%
2022 211 Thousand USD -88.46%
2021 1.82 Million USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%

Peer Total Debt Comparison of NeuroSense Therapeutics Ltd.

Name Total Debt Total Debt Difference
Psyence Biomedical Ltd. 7.65 Million USD 98.146%
XOMA Corporation 124.45 Million USD 99.886%
Mesoblast Limited 118.92 Million USD 99.881%
Xeris Biopharma Holdings, Inc. 229.19 Million USD 99.938%
Aptorum Group Limited 3.36 Million USD 95.777%
Qualigen Therapeutics, Inc. 1.29 Million USD 89.07%
HilleVax, Inc. 51.19 Million USD 99.723%
Rocket Pharmaceuticals, Inc. 25.04 Million USD 99.433%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD 99.32%
Precision BioSciences, Inc. 31.26 Million USD 99.546%
Dyadic International, Inc. 136.92 Thousand USD -3.703%
Intensity Therapeutics, Inc. 158 Thousand USD 10.127%
IDEAYA Biosciences, Inc. 2.87 Million USD 95.056%
Eton Pharmaceuticals, Inc. 5.45 Million USD 97.397%
VYNE Therapeutics Inc. 214 Thousand USD 33.645%
EyePoint Pharmaceuticals, Inc. 5.46 Million USD 97.404%
Adaptive Biotechnologies Corporation 229.43 Million USD 99.938%
Tenaya Therapeutics, Inc. 12.42 Million USD 98.857%
IGM Biosciences, Inc. 40.5 Million USD 99.649%
Opthea Limited 200.62 Million USD 99.929%
Milestone Pharmaceuticals Inc. 51.77 Million USD 99.726%
Abeona Therapeutics Inc. 5.4 Million USD 97.37%
Tonix Pharmaceuticals Holding Corp. 9.81 Million USD 98.553%
Ligand Pharmaceuticals Incorporated 6.16 Million USD 97.697%
NextCure, Inc. 6.6 Million USD 97.85%
Inhibikase Therapeutics, Inc. 622 Thousand USD 77.171%
Ovid Therapeutics Inc. 46 Million USD 99.691%
CASI Pharmaceuticals, Inc. 21.23 Million USD 99.331%
Arcturus Therapeutics Holdings Inc. 30.21 Million USD 99.53%
Syros Pharmaceuticals, Inc. 62.07 Million USD 99.771%
Senti Biosciences, Inc. 37.66 Million USD 99.623%
Apollomics, Inc. 4.66 Million USD 96.953%
PureTech Health plc 25.51 Million USD 99.443%
Oncternal Therapeutics, Inc. 318 Thousand USD 55.346%
Barinthus Biotherapeutics plc 12.97 Million USD 98.906%
Kymera Therapeutics, Inc. 84.67 Million USD 99.832%
ChromaDex Corporation 3.27 Million USD 95.667%
Monopar Therapeutics Inc. - USD -Infinity%
Akebia Therapeutics, Inc. 104.18 Million USD 99.864%
Sangamo Therapeutics, Inc. 38.1 Million USD 99.627%
Dermata Therapeutics, Inc. - USD -Infinity%
Gritstone bio, Inc. 104.77 Million USD 99.864%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Fate Therapeutics, Inc. 103.53 Million USD 99.863%
BioXcel Therapeutics, Inc. 101.38 Million USD 99.86%
Fortress Biotech, Inc. 88.59 Million USD 99.84%
Checkpoint Therapeutics, Inc. - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
Lyell Immunopharma, Inc. 63.16 Million USD 99.775%
Celcuity Inc. 37.44 Million USD 99.621%
ContextLogic Inc. 6 Million USD 97.633%
GH Research PLC 343 Thousand USD 58.601%
HOOKIPA Pharma Inc. 6.55 Million USD 97.835%
Cassava Sciences, Inc. - USD -Infinity%
Cyclacel Pharmaceuticals, Inc. 37 Thousand USD -283.784%
ImmuCell Corporation 11.96 Million USD 98.814%
Amarin Corporation plc 8.73 Million USD 98.375%
TG Therapeutics, Inc. 110.79 Million USD 99.872%
X4 Pharmaceuticals, Inc. 58.28 Million USD 99.756%
Acelyrin, Inc. 1.19 Million USD 88.107%
BriaCell Therapeutics Corp. - USD -Infinity%
Seer, Inc. 28.25 Million USD 99.498%
Novavax, Inc. 280.63 Million USD 99.949%
Phathom Pharmaceuticals, Inc. 139.03 Million USD 99.898%
Jazz Pharmaceuticals plc 5.79 Billion USD 99.998%
AnaptysBio, Inc. 17.81 Million USD 99.203%
Aptevo Therapeutics Inc. 5.39 Million USD 97.369%
PMV Pharmaceuticals, Inc. 13.28 Million USD 98.931%
AbCellera Biologics Inc. 77.38 Million USD 99.816%
CorMedix Inc. 667.63 Thousand USD 78.731%
Cartesian Therapeutics, Inc. 10.95 Million USD 98.704%
Marker Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 99.995%
Aptose Biosciences Inc. 1 Million USD 85.938%
ZyVersa Therapeutics, Inc. 8656.00 USD -1540.481%
Soligenix, Inc. 3.49 Million USD 95.937%
Century Therapeutics, Inc. 48.17 Million USD 99.705%
Arrowhead Pharmaceuticals, Inc. 115.17 Million USD 99.877%
TransCode Therapeutics, Inc. 450.57 Thousand USD 68.484%
Kura Oncology, Inc. 17.2 Million USD 99.174%
RAPT Therapeutics, Inc. 6.9 Million USD 97.944%
Ardelyx, Inc. 55.98 Million USD 99.746%
Ainos, Inc. 5.96 Million USD 97.619%
TScan Therapeutics, Inc. 92.43 Million USD 99.846%
Ocean Biomedical, Inc. 2.15 Million USD 93.395%
Prothena Corporation plc 11.83 Million USD 98.8%
CytomX Therapeutics, Inc. 13.97 Million USD 98.984%
Autolus Therapeutics plc 52.96 Million USD 99.732%
Mineralys Therapeutics, Inc. - USD -Infinity%
Adaptimmune Therapeutics plc 25.23 Million USD 99.437%
Eterna Therapeutics Inc. 41.84 Million USD 99.661%
Celularity Inc. 65.41 Million USD 99.783%
Rallybio Corporation 392 Thousand USD 63.776%
GRI Bio, Inc. 14 Thousand USD -914.286%
Xenetic Biosciences, Inc. - USD -Infinity%
Omeros Corporation 338.28 Million USD 99.958%
INmune Bio, Inc. 10.43 Million USD 98.639%
Heron Therapeutics, Inc. 179.62 Million USD 99.921%
SAB Biotherapeutics, Inc. 5.9 Million USD 97.596%
Pasithea Therapeutics Corp. 81.68 Thousand USD -73.849%
Entero Therapeutics, Inc. 826.84 Thousand USD 82.826%
Humacyte, Inc. 58.1 Million USD 99.756%
Atara Biotherapeutics, Inc. 57.87 Million USD 99.755%
Coherus BioSciences, Inc. 480.84 Million USD 99.97%
Immunocore Holdings plc 84.03 Million USD 99.831%
Cocrystal Pharma, Inc. 1.85 Million USD 92.337%
Verastem, Inc. 41.55 Million USD 99.658%
Pliant Therapeutics, Inc. 11.37 Million USD 98.751%
Histogen Inc. 4.62 Million USD 96.928%
Surrozen, Inc. 3.37 Million USD 95.798%
Blueprint Medicines Corporation 774.12 Million USD 99.982%
Organovo Holdings, Inc. 1.39 Million USD 89.813%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
IO Biotech, Inc. 2.49 Million USD 94.306%
MEI Pharma, Inc. - USD -Infinity%
GT Biopharma, Inc. 58 Thousand USD -144.828%
Centessa Pharmaceuticals plc 84.58 Million USD 99.832%
Hepion Pharmaceuticals, Inc. 209.02 Thousand USD 32.064%
Cabaletta Bio, Inc. 5.01 Million USD 97.17%
Summit Therapeutics Inc. 106.09 Million USD 99.866%
Alaunos Therapeutics, Inc. - USD -Infinity%
Marinus Pharmaceuticals, Inc. 110.35 Million USD 99.871%
BioRestorative Therapies, Inc. 162.31 Thousand USD 12.517%
Turnstone Biologics Corp. 3.21 Million USD 95.582%
Pulmatrix, Inc. 8.75 Million USD 98.378%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd 247 Thousand USD 42.51%
Aurinia Pharmaceuticals Inc. 97.6 Million USD 99.855%
Vigil Neuroscience, Inc. 13.85 Million USD 98.975%
Intellia Therapeutics, Inc. 115.34 Million USD 99.877%
Cytokinetics, Incorporated 755.77 Million USD 99.981%
Exelixis, Inc. 189.94 Million USD 99.925%
Nurix Therapeutics, Inc. 30.61 Million USD 99.536%
Apellis Pharmaceuticals, Inc. 110.92 Million USD 99.872%
Evogene Ltd. 1.13 Million USD 87.522%
Replimune Group, Inc. 75.86 Million USD 99.813%
PDS Biotechnology Corporation 23.85 Million USD 99.405%
Hoth Therapeutics, Inc. 55.16 Thousand USD -157.41%
Jasper Therapeutics, Inc. 2.78 Million USD 94.903%
ESSA Pharma Inc. 80.32 Thousand USD -76.775%
TNF Pharmaceuticals, Inc. 48.87 Thousand USD -190.567%
BioLineRx Ltd. 11.59 Million USD 98.775%
Avid Bioservices, Inc. 207.83 Million USD 99.932%
Insmed Incorporated 1.2 Billion USD 99.988%
VistaGen Therapeutics, Inc. 2.12 Million USD 93.302%
Zentalis Pharmaceuticals, Inc. 45.77 Million USD 99.69%
Sagimet Biosciences Inc. 65 Thousand USD -118.462%
MediWound Ltd. 6.71 Million USD 97.884%
MiMedx Group, Inc. 48.09 Million USD 99.705%
OmniAb, Inc. 25.56 Million USD 99.444%
Alector, Inc. 38.91 Million USD 99.635%
Seres Therapeutics, Inc. 213.93 Million USD 99.934%
PTC Therapeutics, Inc. 415.02 Million USD 99.966%
Mereo BioPharma Group plc 5.95 Million USD 97.614%
Zai Lab Limited 15.15 Million USD 99.063%
Revance Therapeutics, Inc. 478.43 Million USD 99.97%
Syndax Pharmaceuticals, Inc. 1.63 Million USD 91.315%
Aura Biosciences, Inc. 19.55 Million USD 99.274%
Immunic, Inc. 1.33 Million USD 89.355%
Dyne Therapeutics, Inc. 27.41 Million USD 99.482%
Tarsus Pharmaceuticals, Inc. 31.73 Million USD 99.553%
Veracyte, Inc. 12.63 Million USD 98.876%
InMed Pharmaceuticals Inc. 644.86 Million USD 99.978%
FibroGen, Inc. 170.45 Million USD 99.917%
SeaStar Medical Holding Corporation 9.08 Million USD 98.436%
Allakos Inc. 41.46 Million USD 99.658%
scPharmaceuticals Inc. 40.26 Million USD 99.647%
Fulcrum Therapeutics, Inc. 10.82 Million USD 98.688%
Corcept Therapeutics Incorporated 151 Thousand USD 5.96%
Adial Pharmaceuticals, Inc. - USD -Infinity%
NLS Pharmaceutics AG 1.63 Million USD 91.308%
Sonnet BioTherapeutics Holdings, Inc. 203.91 Thousand USD 30.362%
Amylyx Pharmaceuticals, Inc. 4.23 Million USD 96.649%
Precigen, Inc. 7.09 Million USD 97.999%
Fortrea Holdings Inc. 1.67 Billion USD 99.992%
KalVista Pharmaceuticals, Inc. 7.31 Million USD 98.059%
Incyte Corporation 38.28 Million USD 99.629%
Alzamend Neuro, Inc. 300.71 Thousand USD 52.779%
Cara Therapeutics, Inc. 43.16 Million USD 99.671%
XBiotech Inc. - USD -Infinity%
Aligos Therapeutics, Inc. 11.13 Million USD 98.725%
Jasper Therapeutics, Inc. 2.78 Million USD 94.903%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 238.63 Million USD 99.94%
Akero Therapeutics, Inc. 26.04 Million USD 99.455%
Eliem Therapeutics, Inc. 349 Thousand USD 59.312%
Lyra Therapeutics, Inc. 26.88 Million USD 99.472%
Foghorn Therapeutics Inc. 45.07 Million USD 99.685%
Agenus Inc. 350.24 Million USD 99.959%
Kiora Pharmaceuticals, Inc. 106.89 Thousand USD -32.846%
Y-mAbs Therapeutics, Inc. 1.41 Million USD 89.993%
Theravance Biopharma, Inc. 45.23 Million USD 99.686%
Ultragenyx Pharmaceutical Inc. 43.16 Million USD 99.671%
Metagenomi, Inc. Common Stock 48.22 Million USD 99.706%
Lexaria Bioscience Corp. 163.96 Thousand USD 13.397%
BioCryst Pharmaceuticals, Inc. 848.71 Million USD 99.983%
UroGen Pharma Ltd. 100.21 Million USD 99.858%
Gain Therapeutics, Inc. 1.02 Million USD 86.179%
Sutro Biopharma, Inc. 182.74 Million USD 99.922%
Creative Medical Technology Holdings, Inc. 14.19 Thousand USD -900.423%
Lisata Therapeutics, Inc. 305 Thousand USD 53.443%
Chemomab Therapeutics Ltd. 392 Thousand USD 63.776%
Stoke Therapeutics, Inc. 6.83 Million USD 97.922%
Chimerix, Inc. 2.14 Million USD 93.377%
Reneo Pharmaceuticals, Inc. 973 Thousand USD 85.406%
Outlook Therapeutics, Inc. 35.55 Million USD 99.601%
60 Degrees Pharmaceuticals, Inc. 172.67 Thousand USD 17.764%
Pluri Inc. 29.61 Million USD 99.52%
Cue Biopharma, Inc. 14.69 Million USD 99.034%
MeiraGTx Holdings plc 89.26 Million USD 99.841%
Aprea Therapeutics, Inc. - USD -Infinity%
Cadrenal Therapeutics, Inc. Common Stock 21.35 Thousand USD -565.105%
Cidara Therapeutics, Inc. 4.87 Million USD 97.088%
ProMIS Neurosciences, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Scholar Rock Holding Corporation 61.81 Million USD 99.77%
Sana Biotechnology, Inc. 104.09 Million USD 99.864%
Elicio Therapeutics, Inc. 6.91 Million USD 97.947%
NLS Pharmaceutics AG 1.63 Million USD 91.308%
Adlai Nortye Ltd. American Depositary Shares 31.54 Million USD 99.55%
Nutriband Inc. 241.28 Thousand USD 41.148%
Protara Therapeutics, Inc. 5.46 Million USD 97.403%
Vor Biopharma Inc. 35.66 Million USD 99.602%
Roivant Sciences Ltd. 499.74 Million USD 99.972%
ProKidney Corp. 4.41 Million USD 96.782%
Applied Therapeutics, Inc. 1.22 Million USD 88.418%
Daré Bioscience, Inc. 5.31 Million USD 97.33%
BridgeBio Pharma, Inc. 1.73 Billion USD 99.992%
Titan Pharmaceuticals, Inc. 565 Thousand USD 74.867%
Bicycle Therapeutics plc 44.95 Million USD 99.684%
Tango Therapeutics, Inc. 38.92 Million USD 99.635%
Galectin Therapeutics Inc. 71.8 Million USD 99.802%
Revolution Medicines, Inc. Warrant 87.94 Million USD 99.839%
Atai Life Sciences N.V. 16.47 Million USD 99.138%
Renovaro Biosciences Inc. 2.45 Million USD 94.206%
Aerovate Therapeutics, Inc. 675 Thousand USD 78.963%
MediciNova, Inc. 215.92 Thousand USD 34.237%
Praxis Precision Medicines, Inc. 2.49 Million USD 94.309%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD 88.739%
GeoVax Labs, Inc. - USD -Infinity%
Protagonist Therapeutics, Inc. 1.14 Million USD 87.555%
Axsome Therapeutics, Inc. 186.37 Million USD 99.924%
Biomea Fusion, Inc. 10.29 Million USD 98.621%
RenovoRx, Inc. - USD -Infinity%
Erasca, Inc. 55.85 Million USD 99.746%
Cullinan Oncology, Inc. 3.59 Million USD 96.045%
NRx Pharmaceuticals, Inc. 9.16 Million USD 98.45%
4D Molecular Therapeutics, Inc. 14.67 Million USD 99.032%
Kiniksa Pharmaceuticals, Ltd. 12.25 Million USD 98.842%
bluebird bio, Inc. 330.32 Million USD 99.957%
Ventyx Biosciences, Inc. 12.5 Million USD 98.865%
Pieris Pharmaceuticals, Inc. - USD -Infinity%
Imunon, Inc. 1.62 Million USD 91.26%
BioMarin Pharmaceutical Inc. 1.13 Billion USD 99.987%
BioAtla, Inc. 2.46 Million USD 94.228%
Allogene Therapeutics, Inc. 95.12 Million USD 99.851%
Larimar Therapeutics, Inc. 5.54 Million USD 97.44%
DBV Technologies S.A. 14.38 Million USD 99.013%
Fortress Biotech, Inc. 88.59 Million USD 99.84%
Avidity Biosciences, Inc. 9.85 Million USD 98.559%
Kezar Life Sciences, Inc. 18.93 Million USD 99.25%
aTyr Pharma, Inc. 15.09 Million USD 99.059%
Viridian Therapeutics, Inc. 21.04 Million USD 99.325%
EyeGate Pharmaceuticals, Inc. 326.49 Thousand USD 56.507%
Galecto, Inc. 249 Thousand USD 42.972%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. 1.63 Million USD 91.298%
Halozyme Therapeutics, Inc. 1.49 Billion USD 99.991%
Lexicon Pharmaceuticals, Inc. 106.06 Million USD 99.866%
Entera Bio Ltd. 390 Thousand USD 63.59%
Travere Therapeutics, Inc. 404.78 Million USD 99.965%
Sensei Biotherapeutics, Inc. 6.2 Million USD 97.713%
Xencor, Inc. 83.43 Million USD 99.83%
Orchestra BioMed Holdings, Inc. 1.68 Million USD 91.583%
Spruce Biosciences, Inc. 4.6 Million USD 96.919%
Coeptis Therapeutics Holdings, Inc. 1.22 Million USD 88.401%
Vanda Pharmaceuticals Inc. 9.4 Million USD 98.49%
Lexaria Bioscience Corp. 163.96 Thousand USD 13.397%
Portage Biotech Inc. 47 Thousand USD -202.128%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD 88.739%
Olema Pharmaceuticals, Inc. 2.41 Million USD 94.125%
OncoCyte Corporation 2.86 Million USD 95.051%
Processa Pharmaceuticals, Inc. 150.55 Thousand USD 5.682%
Purple Biotech Ltd. 351 Thousand USD 59.544%
CollPlant Biotechnologies Ltd. 3.15 Million USD 95.505%
Onconetix, Inc. 9.88 Million USD 98.564%
MacroGenics, Inc. 33.97 Million USD 99.582%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. 2.03 Million USD 93.019%
Neumora Therapeutics, Inc. Common Stock 5.23 Million USD 97.285%
Ocuphire Pharma, Inc. - USD -Infinity%
Prime Medicine, Inc. 13.63 Million USD 98.958%
Aditxt, Inc. 18.21 Million USD 99.221%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. 26.73 Million USD 99.469%
Curis, Inc. 2.79 Million USD 94.918%
Carmell Therapeutics Corporation 2.13 Million USD 93.353%
Adagene Inc. 22.3 Million USD 99.363%
Achieve Life Sciences, Inc. 16.73 Million USD 99.151%
BeiGene, Ltd. 930.18 Million USD 99.985%
Inhibrx Biosciences, Inc. 210.14 Million USD 99.932%
GlycoMimetics, Inc. 808.4 Thousand USD 82.434%
Maravai LifeSciences Holdings, Inc. 610.96 Million USD 99.977%
Protagenic Therapeutics, Inc. - USD -Infinity%
SciSparc Ltd. 76 Thousand USD -86.842%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. 2.5 Million USD 94.325%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. 82.01 Million USD 99.827%
Fresh Tracks Therapeutics, Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 205.91 Million USD 99.931%
Acrivon Therapeutics, Inc. Common Stock 4.64 Million USD 96.942%
Alnylam Pharmaceuticals, Inc. 2.68 Billion USD 99.995%
ADMA Biologics, Inc. 141.41 Million USD 99.9%
Rigel Pharmaceuticals, Inc. 60.57 Million USD 99.766%
Clene Inc. 32.16 Million USD 99.558%
Celldex Therapeutics, Inc. 2.54 Million USD 94.414%
Cogent Biosciences, Inc. 18.85 Million USD 99.247%
Boundless Bio, Inc. Common Stock 2.19 Million USD 93.531%
Recursion Pharmaceuticals, Inc. 50.67 Million USD 99.72%
Adicet Bio, Inc. 20.92 Million USD 99.321%
Contineum Therapeutics, Inc. Class A Common Stock 193.19 Million USD 99.926%
Absci Corporation 15.95 Million USD 99.11%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 15.3 Million USD 99.072%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 20.29 Million USD 99.3%
Surrozen, Inc. 3.37 Million USD 95.798%
Generation Bio Co. 97.89 Million USD 99.855%
Astria Therapeutics, Inc. 329 Thousand USD 56.839%
Caribou Biosciences, Inc. 27.48 Million USD 99.483%
Black Diamond Therapeutics, Inc. 25.29 Million USD 99.439%
Janux Therapeutics, Inc. 24.54 Million USD 99.421%
Invivyd, Inc. 2.16 Million USD 93.441%
Cingulate Inc. 3.13 Million USD 95.471%
Relay Therapeutics, Inc. 53.46 Million USD 99.734%
Quoin Pharmaceuticals, Ltd. 3523.73 USD -3929.821%
Tenax Therapeutics, Inc. 500.9 Thousand USD 71.651%
Spero Therapeutics, Inc. 5.54 Million USD 97.438%
Jaguar Health, Inc. 35.86 Million USD 99.604%
Artelo Biosciences, Inc. 63 Thousand USD -125.397%
2seventy bio, Inc. 256.67 Million USD 99.945%
Clearside Biomedical, Inc. 43 Million USD 99.67%
Terns Pharmaceuticals, Inc. 603 Thousand USD 76.451%
ACADIA Pharmaceuticals Inc. 57.2 Million USD 99.752%
Capricor Therapeutics, Inc. 5.61 Million USD 97.47%
Citius Pharmaceuticals, Inc. 481.24 Thousand USD 70.493%
Relmada Therapeutics, Inc. - USD -Infinity%
Kronos Bio, Inc. 28.27 Million USD 99.498%
Innoviva, Inc. 449.07 Million USD 99.968%
Bolt Biotherapeutics, Inc. 20.21 Million USD 99.298%
Entrada Therapeutics, Inc. 68.23 Million USD 99.792%
ALX Oncology Holdings Inc. 17.19 Million USD 99.174%
Vir Biotechnology, Inc. 124.54 Million USD 99.886%
Evaxion Biotech A/S 10.86 Million USD 98.694%
Ocular Therapeutix, Inc. 83.38 Million USD 99.83%
Verve Therapeutics, Inc. 74.9 Million USD 99.81%
Tyra Biosciences, Inc. 6.49 Million USD 97.814%
Galmed Pharmaceuticals Ltd. 41 Thousand USD -246.341%
Unity Biotechnology, Inc. 26.99 Million USD 99.474%
Connect Biopharma Holdings Limited 465 Thousand USD 69.462%
Clearmind Medicine Inc. - USD -Infinity%
AlloVir, Inc. 27.42 Million USD 99.482%
ORIC Pharmaceuticals, Inc. 10.21 Million USD 98.61%
Catalyst Pharmaceuticals, Inc. 3.55 Million USD 96.008%
CERo Therapeutics Holdings, Inc. 1.55 Million USD 90.868%
Viking Therapeutics, Inc. 1.26 Million USD 88.73%
Keros Therapeutics, Inc. 14.44 Million USD 99.017%
SELLAS Life Sciences Group, Inc. 906 Thousand USD 84.327%
Crinetics Pharmaceuticals, Inc. 51.72 Million USD 99.725%
ImmunityBio, Inc. 883.67 Million USD 99.984%
Korro Bio, Inc. 33.2 Million USD 99.572%
C4 Therapeutics, Inc. 70.97 Million USD 99.8%
Kineta, Inc. 1.31 Million USD 89.218%
Lantern Pharma Inc. 234.47 Thousand USD 39.438%
BioVie Inc. 6.11 Million USD 97.676%
Codexis, Inc. 22.36 Million USD 99.365%
Celularity Inc. 65.41 Million USD 99.783%
Eledon Pharmaceuticals, Inc. 383 Thousand USD 62.924%
Virax Biolabs Group Limited 224.3 Thousand USD 36.692%
Kodiak Sciences Inc. 181.63 Million USD 99.922%
Cibus, Inc. 24.62 Million USD 99.423%
Annexon, Inc. 31.35 Million USD 99.547%
Assembly Biosciences, Inc. 2.34 Million USD 93.937%
Moderna, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD 99.99%
Adverum Biotechnologies, Inc. 75.03 Million USD 99.811%
Avalo Therapeutics, Inc. 3.9 Million USD 96.362%
Immix Biopharma, Inc. - USD -Infinity%
Eyenovia, Inc. 16.1 Million USD 99.118%
Puma Biotechnology, Inc. 111.49 Million USD 99.873%
Monte Rosa Therapeutics, Inc. 46.03 Million USD 99.692%
Wave Life Sciences Ltd. 32.11 Million USD 99.558%
Conduit Pharmaceuticals Inc. 985 Thousand USD 85.584%
Xilio Therapeutics, Inc. 11.45 Million USD 98.761%
Alkermes plc 290.73 Million USD 99.951%
Arcellx, Inc. 97.62 Million USD 99.855%
Moolec Science SA 2.64 Million USD 94.632%
Cardiff Oncology, Inc. 2.14 Million USD 93.392%
LAVA Therapeutics N.V. 6.31 Million USD 97.751%
Enanta Pharmaceuticals, Inc. 26.51 Million USD 99.464%
Regulus Therapeutics Inc. 3.1 Million USD 95.422%
Atea Pharmaceuticals, Inc. 2.4 Million USD 94.088%
Compass Therapeutics, Inc. 1.73 Million USD 91.806%
Greenwich LifeSciences, Inc. - USD -Infinity%
Humacyte, Inc. 58.1 Million USD 99.756%
Acumen Pharmaceuticals, Inc. 28.48 Million USD 99.502%
Geron Corporation 85.89 Million USD 99.835%
Verrica Pharmaceuticals Inc. 45.51 Million USD 99.688%
Avenue Therapeutics, Inc. - USD -Infinity%
Royalty Pharma plc 6.13 Billion USD 99.998%
TFF Pharmaceuticals, Inc. 115.25 Thousand USD -23.206%
Notable Labs, Ltd. 2.04 Million USD 93.07%
Mersana Therapeutics, Inc. 33.83 Million USD 99.58%
Structure Therapeutics Inc. 5.45 Million USD 97.396%
IN8bio, Inc. 4.89 Million USD 97.098%
89bio, Inc. 27.1 Million USD 99.476%
DiaMedica Therapeutics Inc. 400 Thousand USD 64.5%
Vera Therapeutics, Inc. 53.7 Million USD 99.736%
Acasti Pharma Inc. - USD -Infinity%
Genelux Corporation 2.51 Million USD 94.363%
Trevi Therapeutics, Inc. 1.33 Million USD 89.387%
Liquidia Corporation 3.5 Million USD 95.946%
Mustang Bio, Inc. 2.49 Million USD 94.315%
Immunovant, Inc. 138 Thousand USD -2.899%
Vericel Corporation 88.14 Million USD 99.839%
Quantum-Si incorporated 15.3 Million USD 99.072%
Arbutus Biopharma Corporation 8.72 Million USD 98.372%
XOMA Corporation 124.45 Million USD 99.886%
ARS Pharmaceuticals, Inc. 274 Thousand USD 48.175%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. 81.68 Thousand USD -73.849%
Alpha Tau Medical Ltd. 13.27 Million USD 98.93%
Vaxcyte, Inc. 29.22 Million USD 99.514%
Xenon Pharmaceuticals Inc. 10.9 Million USD 98.698%
Estrella Immunopharma, Inc. - USD -Infinity%
NeuroBo Pharmaceuticals, Inc. 203 Thousand USD 30.049%
Tempest Therapeutics, Inc. 20.66 Million USD 99.313%
Sol-Gel Technologies Ltd. 1.65 Million USD 91.41%
Rhythm Pharmaceuticals, Inc. 1.26 Million USD 88.73%
Soleno Therapeutics, Inc. 403 Thousand USD 64.764%
Enlivex Therapeutics Ltd. 1.03 Million USD 86.24%
PepGen Inc. 20.1 Million USD 99.294%
Moleculin Biotech, Inc. 574 Thousand USD 75.261%
United Therapeutics Corporation 700 Million USD 99.98%
Solid Biosciences Inc. 26.26 Million USD 99.459%
BriaCell Therapeutics Corp. - USD -Infinity%
Conduit Pharmaceuticals Inc. 985 Thousand USD 85.584%
Immuneering Corporation 4.46 Million USD 96.818%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. - USD -Infinity%
Telomir Pharmaceuticals, Inc. Common Stock 101 Thousand USD -40.594%
Belite Bio, Inc 886 Thousand USD 83.973%
Pharming Group N.V. 171.54 Million USD 99.917%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited 239.61 Million USD 99.941%
Pyxis Oncology, Inc. 21.33 Million USD 99.334%
uniQure N.V. 138.4 Million USD 99.897%
Windtree Therapeutics, Inc. 16.83 Million USD 99.156%
GeoVax Labs, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 85.42 Million USD 99.834%
Altimmune, Inc. 671 Thousand USD 78.838%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. 13.27 Million USD 98.93%
Peak Bio, Inc. 10.72 Million USD 98.676%
SeaStar Medical Holding Corporation 9.08 Million USD 98.436%
FibroBiologics, Inc. Common Stock 1.74 Million USD 91.872%
Benitec Biopharma Inc. 284 Thousand USD 50.0%
Zura Bio Limited - USD -Infinity%
Amicus Therapeutics, Inc. 445.05 Million USD 99.968%
Salarius Pharmaceuticals, Inc. 289.64 Thousand USD 50.974%
Compugen Ltd. 1.35 Million USD 89.489%
Elevai Labs, Inc. Common Stock 210.48 Thousand USD 32.538%
argenx SE 20 Million USD 99.29%
Zevra Therapeutics, Inc. 42.76 Million USD 99.668%
Nuvectis Pharma, Inc. - USD -Infinity%
Spyre Therapeutics, Inc. 84.55 Million USD 99.832%
NKGen Biotech, Inc. Common Stock 19.92 Million USD 99.287%
Madrigal Pharmaceuticals, Inc. 117.19 Million USD 99.879%
PolyPid Ltd. 11.77 Million USD 98.794%
Aileron Therapeutics, Inc. 91.45 Million USD 99.845%
Plus Therapeutics, Inc. 4.18 Million USD 96.604%
Forte Biosciences, Inc. - USD -Infinity%
Dianthus Therapeutics, Inc. 585 Thousand USD 75.726%
Instil Bio, Inc. 86.05 Million USD 99.835%
Elevation Oncology, Inc. 30.13 Million USD 99.529%
Immunome, Inc. 1.65 Million USD 91.394%
Verona Pharma plc 51.32 Million USD 99.723%
Enveric Biosciences, Inc. - USD -Infinity%
enGene Holdings Inc. Warrants 9.77 Million USD 98.548%
Shattuck Labs, Inc. 4.2 Million USD 96.621%
LENZ Therapeutics, Inc. 362 Thousand USD 60.773%
Design Therapeutics, Inc. 3.05 Million USD 95.344%
Leap Therapeutics, Inc. 262 Thousand USD 45.802%
Seelos Therapeutics, Inc. 14.22 Million USD 99.002%
Achilles Therapeutics plc 4.61 Million USD 96.923%
Fractyl Health, Inc. Common Stock 373.72 Million USD 99.962%
Rani Therapeutics Holdings, Inc. 30.09 Million USD 99.528%
MoonLake Immunotherapeutics 3.69 Million USD 96.16%
Beam Therapeutics Inc. 173.17 Million USD 99.918%
Moolec Science SA 2.64 Million USD 94.632%
Longboard Pharmaceuticals, Inc. 475 Thousand USD 70.105%
AEON Biopharma, Inc. 278 Thousand USD 48.921%
Aadi Bioscience, Inc. 7.02 Million USD 97.978%
Enliven Therapeutics, Inc. 335 Thousand USD 57.612%
Iovance Biotherapeutics, Inc. 75.86 Million USD 99.813%
Taysha Gene Therapies, Inc. 61.1 Million USD 99.768%
Inovio Pharmaceuticals, Inc. 30.2 Million USD 99.53%
Athira Pharma, Inc. 1.58 Million USD 91.041%
HCW Biologics Inc. 6.45 Million USD 97.799%
XOMA Corporation 124.45 Million USD 99.886%
NeurAxis, Inc. 224.26 Thousand USD 36.681%
Lumos Pharma, Inc. 6.58 Million USD 97.844%
enGene Holdings Inc. Common Stock 9.77 Million USD 98.548%
180 Life Sciences Corp. 1.32 Million USD 89.243%
Nektar Therapeutics 230.4 Million USD 99.938%
NKGen Biotech, Inc. Warrants 19.92 Million USD 99.287%
Opiant Pharmaceuticals, Inc. 17.08 Million USD 99.169%
Arvinas, Inc. 3.4 Million USD 95.824%
CERo Therapeutics Holdings, Inc. 1.55 Million USD 90.868%
Palisade Bio, Inc. 369 Thousand USD 61.518%
Nutriband Inc. 241.28 Thousand USD 41.148%
Tevogen Bio Holdings Inc. 1.63 Million USD 91.298%
CG Oncology, Inc. Common stock 826 Thousand USD 82.809%
Tourmaline Bio, Inc. 415 Thousand USD 65.783%
Merus N.V. 12.16 Million USD 98.832%
Omega Therapeutics, Inc. 128.42 Million USD 99.889%
Neurogene Inc. 16.25 Million USD 99.126%
Mirum Pharmaceuticals, Inc. 308.14 Million USD 99.954%
Kintara Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock 28.54 Million USD 99.502%
Sesen Bio, Inc. - USD -Infinity%
Quince Therapeutics, Inc. 13.81 Million USD 98.972%
Rezolute, Inc. 2.22 Million USD 93.627%
Clene Inc. 32.16 Million USD 99.558%
Indaptus Therapeutics, Inc. 175.05 Thousand USD 18.882%
BeyondSpring Inc. 3.99 Million USD 96.446%
Synlogic, Inc. 17.27 Million USD 99.178%
Allarity Therapeutics, Inc. 1.3 Million USD 89.077%
Phio Pharmaceuticals Corp. 35 Thousand USD -305.714%
Peak Bio, Inc. 10.72 Million USD 98.676%
Werewolf Therapeutics, Inc. 51.92 Million USD 99.727%
Krystal Biotech, Inc. 8.09 Million USD 98.246%
Karyopharm Therapeutics Inc. 177.01 Million USD 99.92%
SpringWorks Therapeutics, Inc. 7.05 Million USD 97.988%
Lipella Pharmaceuticals Inc. 136.59 Thousand USD -3.958%
MannKind Corporation 382.37 Million USD 99.963%
Ikena Oncology, Inc. 10.73 Million USD 98.678%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 409 Thousand USD 65.281%
Gossamer Bio, Inc. 212.46 Million USD 99.933%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. 174 Thousand USD 18.391%
NRx Pharmaceuticals, Inc. 9.16 Million USD 98.45%
Legend Biotech Corporation 328.67 Million USD 99.957%
Mural Oncology plc 15 Million USD 99.054%
Disc Medicine, Inc. 2.1 Million USD 93.241%
Champions Oncology, Inc. 7.43 Million USD 98.089%
REGENXBIO Inc. 89.29 Million USD 99.841%
Ensysce Biosciences, Inc. 854.69 Thousand USD 83.386%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. 552.98 Thousand USD 74.321%
Edgewise Therapeutics, Inc. 5.41 Million USD 97.377%
Vaxart, Inc. 26.51 Million USD 99.464%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. 15.65 Million USD 99.093%
Cellectis S.A. 92.85 Million USD 99.847%
Longeveron Inc. 2.04 Million USD 93.043%
Repare Therapeutics Inc. 3.41 Million USD 95.836%
Sarepta Therapeutics, Inc. 1.39 Billion USD 99.99%
Inozyme Pharma, Inc. 46.59 Million USD 99.695%
Revolution Medicines, Inc. 87.94 Million USD 99.839%
Nymox Pharmaceutical Corporation 173 Thousand USD 17.919%
Third Harmonic Bio, Inc. 3.95 Million USD 96.408%
ArriVent BioPharma, Inc. Common Stock 317 Thousand USD 55.205%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 175 Thousand USD 18.857%
Vertex Pharmaceuticals Incorporated 808.4 Million USD 99.982%
Denali Therapeutics Inc. 52.24 Million USD 99.728%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 14.4 Million USD 99.014%
Corvus Pharmaceuticals, Inc. 1.37 Million USD 89.665%
Cingulate Inc. 3.13 Million USD 95.471%
Passage Bio, Inc. 26.29 Million USD 99.46%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. 6.66 Million USD 97.869%
Day One Biopharmaceuticals, Inc. 408 Thousand USD 65.196%
Oramed Pharmaceuticals Inc. 894 Thousand USD 84.116%
Scinai Immunotherapeutics Ltd. 20.56 Million USD 99.309%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 2.45 Million USD 94.207%
Carisma Therapeutics, Inc. 3.12 Million USD 95.453%
Unicycive Therapeutics, Inc. 811 Thousand USD 82.491%
OmniAb, Inc. 25.56 Million USD 99.444%
Anew Medical, Inc. 1.6 Million USD 91.153%
Fennec Pharmaceuticals Inc. 29.58 Million USD 99.52%
Lipocine Inc. 17.16 Thousand USD -727.217%
Lexeo Therapeutics, Inc. Common Stock 11.63 Million USD 98.78%
Nautilus Biotechnology, Inc. 34.62 Million USD 99.59%
SAB Biotherapeutics, Inc. 5.9 Million USD 97.596%
G1 Therapeutics, Inc. 57.17 Million USD 99.752%
Bellerophon Therapeutics, Inc. 203 Thousand USD 30.049%
Sage Therapeutics, Inc. 5.16 Million USD 97.251%
Ocugen, Inc. 6.94 Million USD 97.954%
Mind Medicine (MindMed) Inc. 14.12 Million USD 98.995%
Q32 Bio Inc. 1.31 Million USD 89.226%
Brainstorm Cell Therapeutics Inc. 672 Thousand USD 78.869%
Alumis Inc. Common Stock 32.58 Million USD 99.564%
Equillium, Inc. 824 Thousand USD 82.767%
Kyverna Therapeutics, Inc. 9.07 Million USD 98.436%
Coya Therapeutics, Inc. - USD -Infinity%
CNS Pharmaceuticals, Inc. 300.8 Thousand USD 52.793%
Dominari Holdings Inc. 3.02 Million USD 95.31%
Edesa Biotech, Inc. 94.48 Thousand USD -50.285%
vTv Therapeutics Inc. 529 Thousand USD 73.157%
Bio-Techne Corporation 419.53 Million USD 99.966%
Agios Pharmaceuticals, Inc. 71.99 Million USD 99.803%
Harmony Biosciences Holdings, Inc. 193.56 Million USD 99.927%
Prelude Therapeutics Incorporated 16.88 Million USD 99.159%
Candel Therapeutics, Inc. 22.76 Million USD 99.376%
iTeos Therapeutics, Inc. 6.05 Million USD 97.656%
Nkarta, Inc. 88.33 Million USD 99.839%
BioCardia, Inc. 1.31 Million USD 89.202%
Iterum Therapeutics plc 19.5 Million USD 99.272%